• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Gynaecological Cancers: Biology and Therapeutics

Gynaecological Cancers: Biology and Therapeutics

9781906985448
856,80 zł
771,12 zł Zniżka 85,68 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 771,12 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Gynaecological cancers are categorised as rare diseases, although collectively they affect over 16,000 women each year in the UK alone. There is a lack of real understanding of these conditions compared with other malignancies, possibly owing to their relative rarity when viewed as individual diseases. The 60th RCOG Study Group brought together a range of experts to examine as many biological aspects of gynaecological cancers as possible, including both surgical and non-surgical therapies. This book presents the findings of the Study Group, with contents including:: • current understanding of the biology of gynaecological cancers • translation of biology to the clinic • state of the art in imaging and therapy • current clinical trials • advances in multimodal therapy • individualised treatment.
Szczegóły produktu
65843
9781906985448
9781906985448

Opis

Rok wydania
2011
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
272
Wymiary (mm)
156.00 x 234.00
Waga (g)
420
  • Part I. Biology of Gynaecological Cancers:: Our Current Understanding:: 1. Morphological sub-types of ovarian carcinoma:: new developments and pathogenesis W. Glenn McCluggage; 2. Novel treatment strategies for targeting genetic changes in endometrial cancer Susana Banerjee; 3. Epigenetic biomarkers in ovarian cancer Robert Brown and Janet Graham; 4. Predictive biology of ovarian cancer Christine A. Parkinson and James D. Brenton; Part II. The Translation of Biology to the Clinic:: 5. Biology of BRCA1 and BRCA2 genes and implications for cancer management Timothy A. Yap, Yvette Drew and Susan Shanley; 6. Implications of homologous recombination defectiveness in ovarian cancer Richard J. Edmondson, Asima Mukhopadhyay, Aiste Cerbinskaite and Nicola J. Curtin; 7. The future of PARP inhibitors in the treatment of cancer Yvette Drew, Timothy A. Yap and Stan B. Kaye; Part III. Imaging and Therapy:: State of the Art:: 8. The role of robotics and the future Tim Mould; 9. Ultra-radical surgery in advanced ovarian cancer Oliver Zivanovic and Dennis S. Chi; 10. Antivascular therapy in gynaecological cancers Leena Mukherjee and Gordon Rustin; 11. Oncolytic viral gene therapy in ovarian cancer Iain A. McNeish; 12. Endometrial cancer:: what have the clinical trials taught us? Andrew Clamp; 13. Targeting therapies in cancer:: opportunities in ovarian cancer Ahmed Ashour Ahmed, Stefan Knapp, Anil K. Sood and Robert C. Bast Jr; 14. Functional imaging:: from tumour biology to the clinic Nandita M. deSouza, Evis Sala, Stavroula Kyriazi and Andrea Rockall; Part IV. What Questions Are Being Asked by Current Clinical Trials?:: 15. Current clinical trials in ovarian cancer Christina Fotopoulou, Angus McIndoe, Jalid Sehouli and Hani Gabra; 16. Clinical trials in cervical cancer Karen Tipples and Melanie Powell; 17. Clinical trials in vulval cancer Tito Lopes; Part V. Consensus Views:: 18. Consensus views arising from the 60th Study Group:: Gynaecological Cancers:: Biology and Therapeutics; Index.
Komentarze (0)